A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

In the wake of dramatic cuts to US Department of Health and Human Services (HHS) staff, cutbacks for state public health ...

More than 170,000 people still sought medical help for acute respiratory infection (ARI), including 22,000 with ...

The sun may be shining but winter viruses are still spreading. Despite the change in season, Covid hospitalisations are at ...

At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featur ...

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...

"My daughter was like a walking virus collection," says a visibly exhausted mother in Nairobi. Her four-year-old tested positive for not one, but four different viruses simultaneously – Influenza A, ...

The Effingham County Health Department is among those feeling the effects of the Trump administration’s termination of public ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), ...